Calusterone |
|
| Trade names | Methosarb, Riedemil |
|---|
| Other names | 7β,17α-Dimethyltestosterone; NSC-88536; U-22550 |
|---|
Routes of administration | By mouth |
|---|
|
(7S,8R,9S,10R,13S,14S,17S)-17-hydroxy-7,10,13,17-tetramethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one
|
| CAS Number | |
|---|
| PubChem CID | |
|---|
| DrugBank | |
|---|
| ChemSpider | |
|---|
| UNII | |
|---|
| KEGG | |
|---|
| ChEMBL | |
|---|
| CompTox Dashboard (EPA) | |
|---|
|
| Formula | C21H32O2 |
|---|
| Molar mass | 316.485 g·mol−1 |
|---|
| 3D model (JSmol) | |
|---|
O=C4\C=C3/[C@]([C@H]2CC[C@]1([C@@H](CC[C@@]1(O)C)[C@@H]2[C@@H](C)C3)C)(C)CC4
|
InChI=1S/C21H32O2/c1-13-11-14-12-15(22)5-8-19(14,2)16-6-9-20(3)17(18(13)16)7-10-21(20,4)23/h12-13,16-18,23H,5-11H2,1-4H3/t13-,16-,17-,18+,19-,20-,21-/m0/s1 Key:IVFYLRMMHVYGJH-PVPPCFLZSA-N
|
Calusterone (INN, USAN) (brand names Methosarb, Riedemil; former developmental code names NSC-88536, U-22550), also known as 7β,17α-dimethyltestosterone, is an orally active anabolic-androgenic steroid (AAS) that is used as an antineoplastic agent.[1][2] It is a 17α-alkylated AAS similar in structure to bolasterone (which is its 7α-isomer).[1]
Androgen/anabolic steroid dosages for breast cancer
| Route |
Medication |
Form |
Dosage
|
| Oral |
Methyltestosterone |
Tablet |
30–200 mg/day
|
| Fluoxymesterone |
Tablet |
10–40 mg 3x/day
|
| Calusterone |
Tablet |
40–80 mg 4x/day
|
| Normethandrone |
Tablet |
40 mg/day
|
| Buccal |
Methyltestosterone |
Tablet |
25–100 mg/day
|
| Injection (IMTooltip intramuscular injection or SCTooltip subcutaneous injection) |
Testosterone propionate |
Oil solution |
50–100 mg 3x/week
|
| Testosterone enanthate |
Oil solution |
200–400 mg 1x/2–4 weeks
|
| Testosterone cypionate |
Oil solution |
200–400 mg 1x/2–4 weeks
|
| Mixed testosterone esters |
Oil solution |
250 mg 1x/week
|
| Methandriol |
Aqueous suspension |
100 mg 3x/week
|
| Androstanolone (DHT) |
Aqueous suspension |
300 mg 3x/week
|
| Drostanolone propionate |
Oil solution |
100 mg 1–3x/week
|
| Metenolone enanthate |
Oil solution |
400 mg 3x/week
|
| Nandrolone decanoate |
Oil solution |
50–100 mg 1x/1–3 weeks
|
| Nandrolone phenylpropionate |
Oil solution |
50–100 mg/week
|
| Note: Dosages are not necessarily equivalent. Sources: See template.
|
Calusterone is on the World Anti-Doping Agency's list of prohibited substances,[3] and is therefore banned from use in most major sports.
References
Androgens and antiandrogens |
|---|
Androgens (incl. AASTooltip anabolic–androgenic steroid) | | ARTooltip Androgen receptor agonists |
- Dihydrotestosterone derivatives: Androstanolone (stanolone, dihydrotestosterone, DHT)
- Androstanolone esters
- Bolazine capronate
- Drostanolone propionate (dromostanolone propionate)
- Epitiostanol
- Mepitiostane
- Mesterolone
- Metenolone acetate (methenolone acetate)
- Metenolone enanthate (methenolone enanthate)
- Stenbolone acetate
- 19-Nortestosterone derivatives: Bolandiol dipropionate
- Nandrolone esters (e.g., nandrolone decanoate, nandrolone phenylpropionate)
- Norclostebol
- Norclostebol acetate
- Oxabolone cipionate (oxabolone cypionate)
- Trenbolone acetate
- Trenbolone hexahydrobenzylcarbonate (trenbolone cyclohexylmethylcarbonate)
- 17α-Alkylated 19-nortestosterone derivatives: Ethylestrenol
- Mibolerone
- Norethandrolone
- Normethandrone (methylestrenolone, normethisterone)
- Propetandrol (propethandrol)
- 17α-Vinyltestosterone derivatives: Norvinisterone (vinylnortestosterone)
|
|---|
| Progonadotropins |
- Antiestrogens (e.g., tamoxifen, clomifene)
- GnRH agonists (e.g., GnRH (gonadorelin), leuprorelin)
- Gonadotropins (e.g., LHTooltip luteinizing hormone, hCGTooltip human chorionic gonadotropin)
|
|---|
|
|---|
| Antiandrogens | | ARTooltip Androgen receptor antagonists |
- Steroidal: Abiraterone acetate +niraparib
- Canrenone
- Chlormadinone acetate
- Cyproterone acetate
- Delmadinone acetate
- Dienogest
- Drospirenone
- Medrogestone
- Megestrol acetate
- Nomegestrol acetate
- Osaterone acetate
- Oxendolone
- Potassium canrenoate
- Spironolactone
|
|---|
Steroidogenesis inhibitors | |
|---|
| Antigonadotropins |
- D2 receptor antagonists (prolactin releasers) (e.g., domperidone, metoclopramide, risperidone, haloperidol, chlorpromazine, sulpiride)
- Estrogens (e.g., bifluranol, diethylstilbestrol, estradiol, estradiol esters, ethinylestradiol, ethinylestradiol sulfonate, paroxypropione)
- GnRH agonists (e.g., leuprorelin)
- GnRH antagonists (e.g., cetrorelix)
- Progestogens (incl., chlormadinone acetate, cyproterone acetate, hydroxyprogesterone caproate, gestonorone caproate, medroxyprogesterone acetate, megestrol acetate)
|
|---|
| Others | |
|---|
|
|---|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
- See also
- Androgen receptor modulators
- Estrogens and antiestrogens
- Progestogens and antiprogestogens
- List of androgens/anabolic steroids
|
Androgen receptor modulators |
|---|
| ARTooltip Androgen receptor | | Agonists | |
|---|
| SARMsTooltip Selective androgen receptor modulator |
- Nonsteroidal: 198RL26
- ACP-105
- AC-262,536
- Acetothiolutamide
- Acetoxolutamide
- Andarine (acetamidoxolutamide, androxolutamide, GTx-007, S-4)
- BMS-564,929
- DTIB
- Enobosarm (ostarine, MK-2866, GTx-024, S-22)
- FTBU-1
- GLPG-0492
- GSK2881078
- GSK-4336A
- GSK-8698
- LG121071 (LGD-121071)
- LGD-2226
- LGD-2941 (LGD-122941)
- LGD-3303
- LGD-4033
- LY305
- JNJ-26146900
- JNJ-28330835
- JNJ-37654032
- OPK-88004 (LY-2452473, TT-701)
- ORM-11984
- PF-06260414
- R-1
- RU-59063
- S-1
- S-23
- S-40503
- S-101479
- Vosilasarm
- Steroidal: EM-9017
- MK-0773
- S42
- TFM-4AS-1
- YK-11
|
|---|
| Antagonists |
- Steroidal: 7α-Thioprogesterone
- 7α-Thiospironolactone
- 7α-Thiomethylspironolactone
- 11α-Hydroxyprogesterone
- 15β-Hydroxycyproterone acetate
- Abiraterone
- Abiraterone acetate
- Allyltestosterone
- Benorterone
- BOMT
- Canrenoic acid
- Canrenone
- Chlormadinone acetate
- Clascoterone
- Clometerone
- Cyproheptadine
- Cyproterone
- Cyproterone acetate
- Delanterone
- Delmadinone acetate
- Dicirenone
- Dienogest
- Drospirenone
- DU-41165
- Edogestrone
- EM-4350
- EM-5854
- EM-5855
- EM-6537
- Epitestosterone
- Galeterone
- Guggulsterone
- Ludaterone
- Medrogestone
- Megestrol acetate
- Mespirenone
- Metogest
- Mexrenone
- Mifepristone
- Nomegestrol acetate
- Nordinone
- Osaterone
- Osaterone acetate
- Oxendolone
- Potassium canrenoate
- Promegestone
- Prorenone
- Rosterolone
- RU-15328
- SC-5233 (spirolactone)
- Spironolactone
- Spirorenone
- Spiroxasone
- Topterone
- Trimegestone
- Trimethyltrienolone (R-2956)
- Zanoterone
|
|---|
|
|---|
| GPRC6A | |
|---|
- See also
- Receptor/signaling modulators
- Androgens and antiandrogens
- Estrogen receptor modulators
- Progesterone receptor modulators
- List of androgens and anabolic steroids
|